Feature Image for Cardiotoxicity and New Therapies

Cardiotoxicity and New Therapies (MS SPOC)

Originally presented September 25, 2019 as part of the UNC Lineberger Cancer Network Medical and Surgical Oncology Lecture Series. Course expires October 22, 2020.

This is a Non-Credit course and does NOT offer continuing education credits.

Presenter

Brian Colwell Jensen, MD
Associate Professor of Medicine
Division of Cardiology
UNC Lineberger Comprehensive Cancer Center
UNC School of Medicine
University of North Carolina at Chapel Hill

Cardiotoxicity and New Therapies

When there is damage to the heart muscle, we call this cardiotoxicity. Brian Jensen, MD, will talk about underlying mechanisms for the cardiotoxicity of kinase inhibitors used to treat cancer.

Learning Outcomes

  • Recognize that kinase inhibitors used in cancer treatment can have adverse cardiovascular effects
  • Recall potential mechanisms for kinase inhibitor-induced cardiotoxicity
  • Identify potential treatments for kinase inhibitor cardiovascular toxicity

Estimated course completion time: 1 hour

Accreditation

This is a Non-Credit course and does NOT offer continuing education credits.

Disclaimer

Please note: This course was published more than one year ago. The facts and conclusions presented may have since changed and may no longer be accurate. Questions about personal health should always be referred to a physician or other health care professional.